Results: Forty-three (76%) patients were males with a median age of 61 years (SD=16.5). A total of 37 (65%) episodes affected the native valve (42% the aortic valve). In 75%, a micro-organism was isolated, of which 88%
Introduction
Infectious endocarditis (IE) is one of the most serious infectious diseases because of its acute and unpredictable clinical course [1] . Despite the steps forward in diagnosis and treatment [2] , its mortality continues to be very high (18% inpatient and 40% at one year from follow-up) [3, 4] . Its treatment consumes a large amount of financial resources because of prolonged hospital stay (arising from long term recommendations for parenteral antimicrobial treatment). However, there are hardly any works that evaluate the overall costs of its hospital treatment.
Efficiency in the healthcare setting is estimated by means of financial evaluation of costs entailed by comprehensive management of the disease. Cost minimization analysis enables selecting the procedure which, with the same effect, has a lower cost [5] . Therefore, alternative care models to traditional hospitalization that reduce or avoid hospital admission without detriment to a benefit on health should markedly increase efficiency during treatment of hospital processes.
Outpatient Parenteral Antimicrobial Therapy (OPAT), is an alternative care model to traditional hospitalization that has been demonstrated to be effective and safe in many infectious processes [6, 7] . Most OPAT programs [8] mainly follow two models. First, infusion in the patient's home with active intervention of nursing personnel called "Healthcare Professional Outpatient Parenteral Antimicrobial Therapy (H-OPAT); and, second, "Selfadministered Outpatient Parenteral Antimicrobial Therapy (S-OPAT)", that is, a model in which the healthcare personnel initially train the patient and/or their caregivers to administer antimicrobials so that healthcare personnel physical presence in the home during infusion is subsequently not necessary. Recently, those of the variant S-OPAT [9] although more limited, are revealing similar efficacy and safety results. In both healthcare processes, the clinician is not too involved in daily follow-up of patients. This is generally limited to monitoring clinical course in the outpatient clinic over a variable period.
In Spain, healthcare expenditure is very high and it is foreseen to increase in the future because of ageing of the population. Sustainability of its healthcare system which is priority in a period of financial crisis such as the one currently will only be possible if we attain maximum efficiency in patient care [10] . Against this backdrop, in our country we have a highly developed system of 150 hospital-at-home units (HAH), in which care devices are managed by internal medicine specialists that provide the patient in their own home diagnosis, care and hospitallike treatments for a limited period just as if they had remained admitted in an acute hospital unit [11] .Most HAHs have a wide list of services for the patient including intravenous antibiotic treatment (OPAT) which over recent years has received considerable attention. Other clinical processes addressed by HAHs include pulmonary embolism, acute kidney injury, post-surgery processes as well as decompensation in chronic diseases including chronic obstructive pulmonary disease and congestive heart failure [12] [13] .HAH has two main treatment A c c e p t e d M a n u s c r i p t regimens according to origin of the patients. In the first, the "admissions avoidance scheme", patients come from emergency services, their homes, retirement homes or outpatient clinics and avoid hospital admission. In the second, patients come from hospital wards and seek to shorten usual hospital admission; this is called "early discharge scheme" (when patients remain less than 7 days in hospital) or "shortened hospital admission scheme" (when the patient is admitted for more than 7 days).
The main difference between stand-alone OPAT and HAH is that, in the latter, there is very close clinical follow-up by healthcare professionals. As such, the patient's safety is increased even in complex clinical processes [14] .
In the specific case of IE published works on OPAT were anecdotal until a few years ago, due mainly to the reticence to incorporate this complex global process into the portfolio of services for this care modality.
However, in the last few years there has been a notable increase in the scientific evidence in this field which coincides with the reiterated support regarding American and European cardiology societies [15] [16] [17] [18] .
However, there are barely any papers published regarding costs arising from treatment of IE both in hospital and for the OPAT care model. Another gap is that S-OPAT in the context of HAH has not been well-described, and most HAH centers do not utilize S-OPAT. The main aim of this study was to determine the efficiency of treatment of IE using S-OPAT with HAH. The former allows reduced nursing effort by training self-or caregiver administration of antimicrobials, while the latter gives the support of a shortening hospital admission program after an initial period (>7 days) of traditional hospitalization.
A c c e p t e d M a n u s c r i p t
Material and Methods

Setting
An ambispective cohort study of patients with IE, diagnosed according to modified Duke criteria [19] , and admitted to the HAH unit in a third level University Hospital in Spain was performed from 1998 to 2014.
The methodology to identify IE episodes and essential characteristics were collected in a database devised for the study. The HAH protocol for IE was applied, in addition to evaluation of the efficacy of the HAH program for S-OPAT having previously been reported [20] .
IE episodes were diagnosed in hospitalized patients, initially treated in hospital until stabilized, and then transferred to the care of the multidisciplinary HAH team. Following stabilization, consensus decisions were taken regarding the optimum S-OPAT schedules to be conducted in the HAH therapeutic plan, which would include not only IE but also any minor complications that may arise. General criteria for S-OPAT treatment of IE within the HAH program are summarized in Table 1 .
The efficiency of S-OPAT was first estimated by calculating the cost per day of stay in the HAH by means of the sum of direct costs (personnel costs, pharmacy consumption, healthcare material, maintenance, amortization of equipment, etc.) and costs charged for other hospital services and structures. We need to point out certain details to understand the cost calculation made. The HAH unit has a care capacity of 56 patients/day and has a physical infrastructure located in hospital. The staff is made up of seven doctors, 17 nurses, seven clinical assistants and two administrative assistants. There are 16 automobiles financed by means of renting to undertake their care work. The healthcare and non-healthcare material together with the pharmacy are supplied by the hospital. Costs are calculated by means of evaluation of direct cost (staff, pharmacy consumption, healthcare material, maintenance, amortization of equipment, etc.) for the unit during 2014; to which we must add the costs charged for other hospital services and structures.
And second, calculating the cost of a day stay in a traditional hospital by means of financial analysis of the 37 patients with IE (25 with entire intrahospital care and 12 with initially intrahospital care and subsequently by means of HAH) who were treated in our hospital and survived during the final years of the study (2013) (2014) with the purpose that the financial data obtained are as reliable as possible. Of the 37 patients analyzed individually, they were included in two different groups; an initial control group of 25 patients that received antibiotic treatment entirely in the hospital; the second case group comprised of the 12 patients who initially received intrahospital treatment followed by treatment in HAH. For each patient, the process and complications presented during the IE episode were evaluated coding for the diagnosis-related group (DRG) generated at discharge. The costs assigned to each DRG were calculated by the hospital's analytical accounting unit using the full cost or total attribution system of costs for the care activity administered. Finally, the comparative analysis A c c e p t e d M a n u s c r i p t
Results
A total of 57 episodes of EI in 54 patients were included in the study;23 episodes were collected from the retrospective period (1998-2007) and 34 were collated prospectively (2008) (2009) (2010) (2011) (2012) (2013) (2014) . This is equivalent to 9.1 % of the total of 624 IE episodes treated by the infectious disease unit of our hospital over that period.
Patients baseline characteristics (basic epidemiological variables, associated comorbidities and history of heart valve disease) and the specific features of the IE episodes are summarized in Table 2 .
The S-OPAT program showed high efficacy as shown by the results summarized in Table 3 . No patient died at home. Clinical complications appeared in approximately 30% of episodes. Six patients had to return to hospital none of whom died in hospital and two of them returned to the HAH unit to complete their S-OPAT. During the one year follow upto the initial episode, two patients presented a relapse of IE: one of them on two occasions, both requiring surgery because intravenous antibiotic treatment failed. In the other patient, the relapse responded favorably to specific antibiotic treatment and did not present subsequent complications.The results of our current series of 57 episodes of IE and those of other series published that applied different OPAT regimens are summarized in Table 4 .
Costs are calculated by means of evaluation of direct cost (staff, pharmacy consumption, healthcare material, maintenance, amortization of equipment, etc.) for the unit during 2014; to which we must add the costs charged for other hospital services and structures (see Table 5 ). The cost of one day stay in HAH is calculated considering the care data for the HAH unit during 2014 that treated 1,567 admissions which generated a total of 20,480 stays. The overall cost of the unit was €3,569,519, whereby the average cost of the stay turned out to be €174. 29 . During the estimate of traditional hospitalization 15 different DRGs were used to evaluate cost arising from treating 37 patients chosen for this purpose. Therefore, weighting for the stays attributed to each DRG generated by the processes involved (1,562 stays) and quantifying the price/stay for each one of them, an average cost of €1166.80 per day stay was determined.
For the comparative analysis of costs between treatment of IE according to the traditional regimen (only hospital) and combined treatment model (initially in hospital, subsequently the HAH unit), we need to ascertain the average stay of both groups of patients. In the case of the control group 25 patients received comprehensive treatment on a hospital ward and their average stay was 49 days. Average stay was also 49 days for the case group of 12 patients that received combined treatment (30 days in hospital and 19 days in the HAH unit). With these data, once the cost/stay of the two models and the number of stays to apply in each one of them are identified, the final results are those shown in Table 6 . That is, the average total cost of treating an episode of IE in hospital was 54,723.22 euros whilst the cost of doing so by applying both care models in a combined fashion The OPAT model has undergone modifications during our study's broad period in accordance with the onset of new antimicrobials and scientific evidence that led to modifications in traditional antimicrobial recommendations for different infectious processes [21] Treatment at home by means of various care modalities of infections with traditional criteria for hospitalization is now consolidated with excellent results regarding efficacy, reducing hospital stays, reducing costs of the process and proving to be satisfactory for the patient [22, 23] . In the case of IE, because this is a complex infectious process, it was incorporated into treatment under this care model at a late stage, whereby there is little prior experience in this regard [20, 24, 25] . Nonetheless, the repeated support shown both by the American Heart Association (AHA) [17, 18] and the European Society of Cardiology (ESC) [15, 16] in the last few years, including OPAT in its clinical guidelines as a care modality for IE in selected patients, has led to an increased publication of works, thereby guaranteeing this care option [26] [27] [28] [29] [30] [31] .
To date, in most published series on OPAT for IE the H-OPAT model predominated; S-OPAT was clearly the minority option. In our previous work [20] we observe that, because the characteristics of patients and episodes of IE were very similar to previous series, the efficacy of the S-OPAT program was excellent because no patient died and the rate of unexpected returns to hospital and relapse was similar to that of other recently published series [28, 31] . Moreover, the paper we present here extends the previously published seriesby9 episodes and is the largest series published in the literature of IE patients who underwent S-OPAT. The results found not only consolidate those obtained previously but they improve them. Our work verifies that the S-OPAT care model is safe and effective to treat IE. Therefore, our care alternative obtains similar healthcare results to the traditional hospitalization model. Furthermore, our data show that between the two care procedures the combined treatment strategy is clearly more efficient than the classical strategy and provides an estimated cost saving of almost 33%.
In a recent review of the OPAT model it was notified that this represents a significant cost reduction in comparison to the traditional hospitalization model but there are still insufficient studies to generalize this statement [32] . In the last few years, papers have been published that try to confirm that this care model, in addition to being effective and safe, is also efficient. Most works are based on the Anglo-Saxon variant of H-OPAT and the methodology used for the financial analysis consists of determining the potential saving arising from less day stay cost attributed to the OPAT in comparison to traditional hospitalization [22, [33] [34] [35] [36] .A British OPAT group evaluated 338 acute infectious processes; OPAT turned out to be 41% cheaper compared to an
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A c c e p t e d M a n u s c r i p t infectious diseases hospital ward [22] . An American group [33] analyzed 398 clinical processes, where OPAT meant a saving for the hospital of $4 million. Another Canadian study estimated a day cost for OPAT of 14% compared to traditional hospitalization [34] .
Our work provides data on the day stay cost of our HAH but also because it comprehensively lists both direct and indirect costs attributed to our model, a model which has not been comprehensively studied and for which there is very little literature. In this regard, there are no financial evaluation works comparing the different variants of our OPAT. However, the few studies published [35, 36] , appear to support the fact that the S-OPAT modality reduces costs more than the H-OPAT model. An American group [35] notified that the cost of the S-OPAT represented 10% of the cost of hospitalization. Subedi S, et al [36] estimated in Australia that the cost of the S-OPAT was $150 per day stay whilst in hospital it was $500-800. According to all the studies, the reduced price of the process in comparison to H-OPAT would mainly be due to the cost reduction arising from nursing staff given that because it is the patient themself and their caregivers who administer S-OPAT, this leads to a drastic reduction in visits by this staff.
We also estimated a day stay cost of the HAH of €174.29, very similar to that published in most articles on S-OPAT. However, because the HAH is based on the complexity of our S-OPAT model, this is much higher than that of any other variant of the OPAT model, whereby we can state that in this context, our model increases the efficiency of the S-OPAT even further if possible.
In the scope of IE, the little information available on the costs of its treatment in a traditional hospitalization unit is surprising. IE is probably one of the most expensive infectious diseases within the portfolio of services offered by a tertiary level hospital. A French group [37] recently published the financial costs of treating IE, resulting in an average cost of €17,735 in 2009, which increased by 34% during the three years the study lasted. In our study, we estimated an average cost of treating an episode of IE at €54,733.22, figures well above that published by the French group although we believe our figure is more accurate. Possibly their data are underestimated because the baseline analysis in the DRG assigned exclusively to IE and obviously, this method is incomplete because it does not evaluate each patient individually and we lose data for those complications that occur during the entire clinical course of the disease.
Another French OPAT group [38] published a retrospective study of 39 episodes of IE treated in the hospital, of which 18 were selected for H-OPAT. The study revealed a day stay price of €140 (not accounting for pharmaceutical costs) H-OPAT; the price of hospital day stay in an infectious disease unit was €1140, meaning a final saving of €14,850 per patient. In our series, not only did we obtain higher efficiency given that we saved almost €3000 more per episode of IE but there was also a higher level of safety. They reported a readmission rate A c c e p t e d M a n u s c r i p t of 17.5% whilst in our case this was 10.5%. These data are of great interest because it confirms that our S-OPAT model is not only more efficient but also safer than the H-OPAT model. The OPAT model in Spain [12, 13] is applied thanks to HAH units, which provide comprehensive management of the infectious disease at the patient's home, because professionals travel to the home to perform clinical monitoring during the disease. In the Anglo-Saxon model follow-up is performed by the nurse whilst the professional remains at the hospital where the patient comes to be periodically re-evaluated [14] .Regular visits at home by the professional guarantee similar clinical outcome to that offered in hospital, thereby increasing the patient's safety by being able to detect the onset of complications early and commence their treatment earlier, thereby avoiding readmission to hospital.
Our results have a high degree of internal validity in that the record of data from variables chosen for the study was comprehensive and there was no loss of information. Further, the health-care scheme of the S-OPAT was supported by the HAH team which has had many years of experience in this area. Since its origins in 1984, the administration of intravenous drugs has formed part of the list of services for patients at home. However, this study has some limitations. First, the specific characteristics of our HAH Unit are dependent on a (University) hospital providing advanced care in close collaboration with medical and surgical specialists involved in the management of IE. It can respond rapidly to any clinical incident in the patient's home. All these characteristics make it difficult to extrapolate our conclusions on the safety and efficacy of the health-care model to other health-care contexts. Second, the low number of patients included in our study sample would tend to limit the reproducibility of our scheme in other contexts.
Conclusion
In summary, IE is a very expensive clinical process; an average of €54,723 per episode is estimated and the application of two combined care models (initially traditional hospitalization and, subsequently, hospitalizationat-home) clearly increases its efficiency because this means a cost saving of 32.72% without undermining safety and effectiveness.
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